house · trading 2017-05-04 → 2026-07-07
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
By recent-buy return, Rohit Khanna ranks #86 of 122 lawmakers — in the bottom 70%.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2018-02-23 | EQIX | BUY | $1K–$15K | $394.84 | $1044.41 2026-08-28 | +164.5% |
| 2018-02-23 | ADS | BUY | $1K–$15K | — | — | — |
| 2018-02-05 | VRIG | BUY | $1K–$15K | $25.18 | $25.04 2026-08-28 | -0.6% |
| 2017-11-01 | NFLX | BUY | $1K–$15K | $19.80 | $81.72 2026-08-28 | +312.7% |
| 2017-10-12 | SPY | BUY | $1K–$15K | $254.64 | $769.35 2026-08-28 | +202.1% |
| 2017-10-11 | SP | BUY | $1K–$15K | — | — | — |
| 2017-07-05 | NVDA | BUY | $1K–$15K | $3.58 | $217.55 2026-08-28 | +5983.2% |
| 2017-06-14 | GSK | BUY | $1K–$15K | $43.62 | $50.82 2026-08-28 | +16.5% |
| 2017-06-09 | NVDA | BUY | $1K–$15K | $3.74 | $217.55 2026-08-28 | +5716.8% |
| 2017-05-04 | GSK | exchange | $1K–$15K | $41.75 | $50.82 2026-08-28 | +21.7% |
| 2017-05-04 | GE | SELL | $1K–$15K | $139.94 | $342.58 2026-08-28 | -144.8% exit |
| FB | BUY | $1K–$15K | — | — | — | |
| EL | BUY | $1K–$15K | — | — | — | |
| AGN | BUY | $1K–$15K | — | — | — | |
| WBA | BUY | $1K–$15K | — | — | — | |
| PLTR | BUY | $1K–$15K | — | — | — | |
| OXY | BUY | $1K–$15K | — | — | — | |
| OGE | BUY | $1K–$15K | — | — | — | |
| CNP | BUY | $1K–$15K | — | — | — | |
| BALL | BUY | $1K–$15K | — | — | — | |
| AMZN | BUY | $1K–$15K | — | — | — | |
| SP | BUY | $1K–$15K | — | — | — | |
| XOM | BUY | $1K–$15K | — | — | — | |
| EPD | BUY | $1K–$15K | — | — | — |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Alan Armstrong | 117 · GE, INTU, MMM, XOM, AMZN, PLTR |
| James B. Renacci | 94 · DAL, GE, GSK, MOT, INTU, MMM |
| Josh Gottheimer | 74 · DAL, INTU, MMM, XOM, AMZN, ALGN |
| Thomas H Tuberville | 73 · GE, GSK, INTU, MMM, XOM, OXY |
| Sheldon Whitehouse | 63 · DAL, GE, MMM, AMZN, WBA, MSFT |
| SUSAN M COLLINS | 62 · DAL, GE, MMM, XOM, AMZN, OXY |
| John A. Yarmuth | 60 · DAL, GE, MMM, XOM, AMZN, APD |
| David A Perdue , Jr | 58 · DAL, GE, EPD, XOM, AMZN, WBA |
| Shelley M Capito | 58 · GE, MMM, XOM, AMZN, OXY, APD |
| Alan S. Lowenthal | 57 · DAL, GE, EQIX, INTU, AMZN, CMG |
| David P. Roe | 57 · GSK, AMZN, CNP, WBA, MSFT, AIG |
| Kurt Schrader | 55 · DAL, GE, GSK, EQIX, XOM, AMZN |